
On January 25, the Eye and ENT Hospital of Fudan University, along with collaborators from Harvard Medical School, Southeast University, and Shanghai Dingxin Gene Technology Co., Ltd., published a groundbreaking clinical trial titled “AAV1-hOTOF Gene Therapy for Autosomal Recessive Deafness 9: a single-arm trial” in the esteemed medical journal The Lancet (Impact Factor: 169), marking the world’s first successful clinical trial of gene therapy for congenital hearing loss.
The study demonstra...
More